JP2014520163A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014520163A5 JP2014520163A5 JP2014517397A JP2014517397A JP2014520163A5 JP 2014520163 A5 JP2014520163 A5 JP 2014520163A5 JP 2014517397 A JP2014517397 A JP 2014517397A JP 2014517397 A JP2014517397 A JP 2014517397A JP 2014520163 A5 JP2014520163 A5 JP 2014520163A5
- Authority
- JP
- Japan
- Prior art keywords
- ring group
- membered
- alkyl
- halogen
- pharmaceutically acceptable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 125000003003 spiro group Chemical group 0.000 claims 26
- 125000000217 alkyl group Chemical group 0.000 claims 22
- 229910052736 halogen Inorganic materials 0.000 claims 20
- 150000002367 halogens Chemical class 0.000 claims 20
- 125000004432 carbon atom Chemical group C* 0.000 claims 15
- 229910052739 hydrogen Inorganic materials 0.000 claims 15
- 239000001257 hydrogen Substances 0.000 claims 15
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 14
- 150000002148 esters Chemical class 0.000 claims 14
- 229910052760 oxygen Inorganic materials 0.000 claims 14
- 150000003839 salts Chemical class 0.000 claims 14
- 229910052717 sulfur Inorganic materials 0.000 claims 14
- 150000001875 compounds Chemical class 0.000 claims 13
- 125000005842 heteroatom Chemical group 0.000 claims 13
- 125000003545 alkoxy group Chemical group 0.000 claims 11
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 9
- -1 —NR 7 R 7a Chemical group 0.000 claims 9
- 125000000753 cycloalkyl group Chemical group 0.000 claims 7
- 125000003118 aryl group Chemical group 0.000 claims 6
- 125000000623 heterocyclic group Chemical group 0.000 claims 6
- 125000001424 substituent group Chemical group 0.000 claims 6
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims 5
- 125000002947 alkylene group Chemical group 0.000 claims 4
- 125000004397 aminosulfonyl group Chemical group NS(=O)(=O)* 0.000 claims 4
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims 4
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 claims 4
- 125000003342 alkenyl group Chemical group 0.000 claims 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 3
- 125000000304 alkynyl group Chemical group 0.000 claims 2
- 125000005129 aryl carbonyl group Chemical group 0.000 claims 2
- 229910052799 carbon Inorganic materials 0.000 claims 2
- 206010012601 diabetes mellitus Diseases 0.000 claims 2
- 201000010099 disease Diseases 0.000 claims 2
- 125000005740 oxycarbonyl group Chemical group [*:1]OC([*:2])=O 0.000 claims 2
- 238000002360 preparation method Methods 0.000 claims 2
- 239000000126 substance Substances 0.000 claims 2
- 208000001072 type 2 diabetes mellitus Diseases 0.000 claims 2
- 125000003601 C2-C6 alkynyl group Chemical group 0.000 claims 1
- 206010022489 Insulin Resistance Diseases 0.000 claims 1
- 208000008589 Obesity Diseases 0.000 claims 1
- 102000000070 Sodium-Glucose Transport Proteins Human genes 0.000 claims 1
- 108010080361 Sodium-Glucose Transport Proteins Proteins 0.000 claims 1
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 claims 1
- 125000002877 alkyl aryl group Chemical group 0.000 claims 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 1
- 125000004093 cyano group Chemical group *C#N 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- 239000002552 dosage form Substances 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 150000002431 hydrogen Chemical class 0.000 claims 1
- 239000003112 inhibitor Substances 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 229910052757 nitrogen Inorganic materials 0.000 claims 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims 1
- 238000007344 nucleophilic reaction Methods 0.000 claims 1
- 235000020824 obesity Nutrition 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 238000011321 prophylaxis Methods 0.000 claims 1
- 238000011282 treatment Methods 0.000 claims 1
- 208000035408 type 1 diabetes mellitus 1 Diseases 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201110188186.4 | 2011-06-25 | ||
| CN201110188186 | 2011-06-25 | ||
| CN201110435397.3 | 2011-12-22 | ||
| CN201110435397 | 2011-12-22 | ||
| PCT/CN2012/000868 WO2013000275A1 (zh) | 2011-06-25 | 2012-06-25 | C-糖苷衍生物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014520163A JP2014520163A (ja) | 2014-08-21 |
| JP2014520163A5 true JP2014520163A5 (enExample) | 2014-10-02 |
| JP5875678B2 JP5875678B2 (ja) | 2016-03-02 |
Family
ID=47423418
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014517397A Active JP5875678B2 (ja) | 2011-06-25 | 2012-06-25 | Ｃ−グルコシド誘導体 |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US9562029B2 (enExample) |
| EP (1) | EP2725031B1 (enExample) |
| JP (1) | JP5875678B2 (enExample) |
| KR (1) | KR101719758B1 (enExample) |
| CN (1) | CN102875503B (enExample) |
| WO (1) | WO2013000275A1 (enExample) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101719758B1 (ko) | 2011-06-25 | 2017-03-24 | 수안주 파마 코포레이션 리미티드 | 씨 글루코사이드 유도체 |
| EP2895490B1 (en) | 2013-09-27 | 2016-10-19 | Sunshine Lake Pharma Co., Ltd. | Glucopyranosyl derivatives and their uses in medicine |
| CN104761522B (zh) * | 2014-01-03 | 2017-02-15 | 山东轩竹医药科技有限公司 | 光学纯的苄基‑4‑氯苯基的c‑糖苷衍生物 |
| US9315438B2 (en) | 2014-01-03 | 2016-04-19 | Xuanzhu Pharma Co., Ltd | Optically pure benzyl-4-chlorophenyl-C-glucoside derivative |
| ES2593050T3 (es) | 2014-01-03 | 2016-12-05 | Xuanzhu Pharma Co., Ltd. | Derivados bencil-4-clorofenil-C-glucósidos ópticamente puros como inhibidores del SGLT (diabetes mellitus) |
| CN105001213B (zh) * | 2014-04-14 | 2020-08-28 | 上海迪诺医药科技有限公司 | C-芳基糖苷衍生物、其药物组合物、制备方法及应用 |
| CN105017236A (zh) * | 2014-04-14 | 2015-11-04 | 上海迪诺医药科技有限公司 | C-芳基糖苷衍生物、其药物组合物、制备方法及应用 |
| KR101721914B1 (ko) | 2015-07-13 | 2017-04-03 | 한국항공우주연구원 | 접이식이동카트를 설치한 운송컨테이너 |
| US11081647B2 (en) * | 2016-04-22 | 2021-08-03 | Universal Display Corporation | Organic electroluminescent materials and devices |
| KR102226465B1 (ko) * | 2016-05-28 | 2021-03-11 | 하이난 수안주 파마 코포레이션 리미티드 | 나트륨-글루코스 공수송체 2에 대한 억제제의 결정형 |
| WO2019185026A1 (zh) * | 2018-03-30 | 2019-10-03 | 南京明德新药研发有限公司 | 作为SGLTs抑制剂的葡糖苷类衍生物及其应用 |
| CN110551088B (zh) * | 2018-06-01 | 2022-10-21 | 北京惠之衡生物科技有限公司 | 氘修饰的苄基-4-氯苯基的c-糖苷衍生物 |
| CN113248554A (zh) * | 2021-06-25 | 2021-08-13 | 北京惠之衡生物科技有限公司 | 一种c-糖苷类衍生物的杂质的合成方法 |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5558287A (en) | 1995-02-02 | 1996-09-24 | Lucent Technologies Inc. | Apparatus and method to prevent flailing damage to a strand wound on a spool |
| JP3820037B2 (ja) * | 1998-11-05 | 2006-09-13 | 三井化学株式会社 | 光記録媒体 |
| US7375125B2 (en) | 1999-08-04 | 2008-05-20 | Ore Pharmaceuticals, Inc. | Melanocortin-4 receptor binding compounds and methods of use thereof |
| US6515117B2 (en) | 1999-10-12 | 2003-02-04 | Bristol-Myers Squibb Company | C-aryl glucoside SGLT2 inhibitors and method |
| PH12000002657B1 (en) | 1999-10-12 | 2006-02-21 | Bristol Myers Squibb Co | C-aryl glucoside SGLT2 inhibitors |
| WO2003035650A1 (en) | 2001-09-25 | 2003-05-01 | Takeda Chemical Industries, Ltd. | Entry inhibitor |
| JP4651934B2 (ja) * | 2002-12-04 | 2011-03-16 | キッセイ薬品工業株式会社 | ベンジルフェノール誘導体、それを含有する医薬組成物およびその医薬用途 |
| EP1581543A4 (en) | 2003-01-03 | 2008-03-19 | Bristol Myers Squibb Co | METHODS FOR PRODUCING SGLT2 GLYCOSIS C-ARYL INHIBITORS |
| JP2004300102A (ja) | 2003-03-31 | 2004-10-28 | Kissei Pharmaceut Co Ltd | 縮合複素環誘導体、それを含有する医薬組成物およびその医薬用途 |
| EP1696708A4 (en) * | 2003-12-15 | 2008-04-23 | Idemitsu Kosan Co | FABRIC FOR ORGANIC ELECTROLUMINESCENZING DEVICE AND BASED ORGANIC ELECTROLUMINESCENSE DEVICE |
| CN103435581B (zh) * | 2004-03-16 | 2015-08-19 | 贝林格尔.英格海姆国际有限公司 | 吡喃葡萄糖基取代的苯基衍生物、含该化合物的药物、其用途及其制造方法 |
| DE102004012676A1 (de) * | 2004-03-16 | 2005-10-06 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Glucopyranosyl-substituierte Phenyle, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung |
| US7772191B2 (en) | 2005-05-10 | 2010-08-10 | Boehringer Ingelheim International Gmbh | Processes for preparing of glucopyranosyl-substituted benzyl-benzene derivatives and intermediates therein |
| EA200801773A1 (ru) | 2006-02-15 | 2009-02-27 | Бёрингер Ингельхайм Интернациональ Гмбх | Глюкопиранозилзамещенные производные бензонитрила, фармацевтические композиции, содержащие такие соединения, их применение и способ их получения |
| AR061026A1 (es) | 2006-05-19 | 2008-07-30 | Taisho Pharmaceutical Co Ltd | Compuesto glicitol c-fenilo y preparacion farmaceutica |
| TW200846441A (en) | 2007-05-17 | 2008-12-01 | Tetrahedron Technology Corp | Fluorescence main host material and organic electroluminescence device using the material |
| EP3318562A3 (en) | 2007-08-23 | 2018-09-12 | Theracos Sub, LLC | Benzylbenzene derivatives and methods of use |
| US8420234B2 (en) * | 2009-01-06 | 2013-04-16 | Udc Ireland Limited | Organic electroluminescent device |
| US8541380B2 (en) | 2009-06-19 | 2013-09-24 | Green Cross Corporation | C-aryl glucoside SGLT2 inhibitors and pharmaceutical compositions comprising same |
| KR20110065978A (ko) | 2009-12-10 | 2011-06-16 | 엘지디스플레이 주식회사 | 적색 인광 호스트 화합물 및 이를 사용한 유기전계발광소자 |
| NZ601658A (en) | 2010-03-18 | 2014-08-29 | Daiichi Sankyo Co Ltd | Cycloalkyl-substituted imidazole derivative |
| WO2012025857A1 (en) | 2010-08-23 | 2012-03-01 | Hetero Research Foundation | Cycloalkyl methoxybenzyl phenyl pyran derivatives as sodium dependent glucose co transporter (sglt2) inhibitors |
| KR101719758B1 (ko) | 2011-06-25 | 2017-03-24 | 수안주 파마 코포레이션 리미티드 | 씨 글루코사이드 유도체 |
| US9315438B2 (en) | 2014-01-03 | 2016-04-19 | Xuanzhu Pharma Co., Ltd | Optically pure benzyl-4-chlorophenyl-C-glucoside derivative |
-
2012
- 2012-06-25 KR KR1020147002034A patent/KR101719758B1/ko active Active
- 2012-06-25 CN CN201210212402.9A patent/CN102875503B/zh active Active
- 2012-06-25 JP JP2014517397A patent/JP5875678B2/ja active Active
- 2012-06-25 WO PCT/CN2012/000868 patent/WO2013000275A1/zh not_active Ceased
- 2012-06-25 US US14/129,316 patent/US9562029B2/en active Active
- 2012-06-25 EP EP12805011.9A patent/EP2725031B1/en active Active
-
2016
- 2016-12-19 US US15/383,885 patent/US10253010B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014520163A5 (enExample) | ||
| RU2011108281A (ru) | Трипиридилкарбоксамидные антагонисты орексиновых рецепторов | |
| RU2012112050A (ru) | Производные дигидроптеридинона, способ их получения и фармацевтическое применение | |
| NZ598085A (en) | Methods, compounds, and compositions for delivering 1,3-propanedisulfonic acid | |
| JP2013512277A5 (enExample) | ||
| JP2012236838A5 (enExample) | ||
| JP2012513416A5 (enExample) | ||
| RU2006133898A (ru) | Производные бензимидазола и его применение | |
| JP2009120598A5 (enExample) | ||
| JP2008513498A5 (enExample) | ||
| JP2011528658A5 (enExample) | ||
| RU2006142738A (ru) | Антагонисты рецептора crth2 | |
| JP2010523522A5 (enExample) | ||
| JP2010155827A5 (enExample) | ||
| RU2013107748A (ru) | Производные с-арилглюкозидов, способ их получения и фармацевтическое применение | |
| WO2009082268A3 (ru) | ЛИГАНДЫ α-АДРЕНОЦЕПТОРОВ, ДОПАМИНОВЫХ, ГИСТАМИНОВЫХ, ИМИДАЗОЛИНОВЫХ И СЕРОТОНИНОВЫХ РЕЦЕПТОРОВ И ИХ ПРИМЕНЕНИЕ | |
| JP2013509392A5 (enExample) | ||
| RU2012146875A (ru) | Азациклические спиропроизводные в качестве ингибиторов hsl | |
| RU2009123525A (ru) | ПРОИЗВОДНЫЕ 5-СУЛЬФАНИЛМЕТИЛ[1,2,4}ТРИАЗОЛ[1,5-а]ПИРИМИДИН-7-ОЛА В КАЧЕСТВЕ АНТАГОНИСТОВ CXCR2 | |
| JP2010522710A5 (enExample) | ||
| RU2015116540A (ru) | Замещенные соединения спиропиперидинила, применяемые в качестве агонистов gpr120 | |
| JP2007507494A5 (enExample) | ||
| JP2013537240A5 (enExample) | ||
| JP2017522304A5 (enExample) | ||
| JP2011046708A5 (enExample) |